TNFSF13B and dermatomyositis: Serum levels of both BAFF and anti-Jo-1 were comparable between subgroups of patients with DM and PM (Table 1; BAFF, p = 0.30; anti-Jo-1, p = 0.13), and with or without ILD (median and range of BAFF: ILD = 1.8, 0.5–20.9, and non-ILD = 1.5, 0.3–8.6 ng/ml; p = 0.56; or anti-Jo-1: ILD = 173.6, 0.8–3604, and non-ILD = 151.8, 0.55–2063 kU/l; p = 0.36).